Files
Download Full Text (3.0 MB)
Contents
- Treating Neurofibromatosis
- Personalized Therapy for Lung Cancer
- House Call: Genetic Screening for Cancer Risks Gives Patients Options
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
11-2009
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Slopis, John; McCutcheon, Ian E.; Kurzrock, Razelle; Lev, Dina; Moore, Bartlett; Wu, Xifeng; Komaki, RItsuko; Herbst, Roy; Wistuba, Ignacio; Arun, Banu; Neurofibromatosis 1; Neurofibromatosis 2; Genes, Neurofibromatosis 1; Neurofibrosarcoma; Schwann Cells; Nerve Sheath Neoplasms; Antineoplastic Agents; Radiotherapy; Sirolimus; Attention Deficit Disorder with Hyperactivity; Dyslexia; Urinary Bladder Neoplasms; PSCA protein, human; Small Cell Lung Carcinoma; Esophagitis; Clinical Trials as Topic; Lung Neoplasms; Precision Medicine; Carcinoma, Non-Small-Cell Lung; Biopsy, Large-Core Needle; Molecular Targeted Therapy; Carcinogenesis; vandetanib; Docetaxel; Genes, BRCA1; Genes, BRCA2; Colorectal Neoplasms, Hereditary Nonpolyposis; Hamartoma Syndrome, Multiple; PTEN Phosphohydrolase; Gardner Syndrome; Li-Fraumeni Syndrome; von Hippel-Lindau Disease
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Chalaire, Dawn and Munch, Joe, "OncoLog Volume 54, Number 11/12, November/December 2009" (2009). OncoLog MD Anderson's Report to Physicians (All issues). 197.
https://openworks.mdanderson.org/oncolog/197
Conditions Governing Access
Open
